Prasugrel Hydrochloride Tablet 10 Mg – EFIGREL 10

Prasugrel Hydrochloride Tablet 10 Mg – A rapid, potent antiplatelet action and efficacy in high-risk patients.

EFIGREL 10: Prasugrel Hydrochloride 10 mg is an antiplatelet medication in the thienopyridine class. It inhibits platelet aggregation by irreversibly blocking the P2Y12 ADP receptor on platelets, preventing the formation of blood clots. Prasugrel is commonly used in patients with acute coronary syndrome (ACS) who are undergoing percutaneous coronary intervention (PCI). By reducing the risk of thrombotic events, Prasugrel lowers the likelihood of complications such as heart attacks and strokes in high-risk patients.

Recommended By Specialists:
Cardiologists: It is mainly used for the treatment of the disease associated with acute coronary syndrome, myocardial infarction (heart attack), or post-angioplasty care.
General Physicians: It is mainly used to treat diseases associated with managing long-term cardiac patients under supervision.

Key benefits of Prasugrel Hydrochloride Tablet 10 Mg – EFIGREL 10
Rapid and Potent Antiplatelet Effect: Prasugrel has a faster onset and more substantial antiplatelet effect compared to other agents like clopidogrel, providing more immediate protection against clot formation.
Reduced Risk of Stent Thrombosis: Prasugrel is particularly effective in preventing stent thrombosis in patients undergoing PCI, reducing the risk of adverse events post-procedure.
Superior Efficacy for High-Risk Patients: Especially beneficial for patients with diabetes or those who have suffered a previous myocardial infarction, Prasugrel has shown better efficacy in preventing recurrent cardiovascular events compared to other antiplatelet agents.

INDICATIONS:
Acute coronary syndrome (ACS)
Post-percutaneous coronary intervention (PCI)
Secondary prevention of cardiovascular events